Company / Financials
Fortress Biotech, Inc. Financials
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$57.7M
FY2025 · -31.8% YoY
Net Income
-$46.0M
FY2025 · +24.1% YoY
Profit Margin
-79.8%
FY2025 · net income / revenue
ROE
-92.2%
FY2025 · return on equity
Total Assets
$185.5M
FY2025
Total Debt
$52.4M
1.05x debt/equity
Equity
$49.9M
FY2025
ROA
-24.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$57.7M-31.8% YoYNet Income HistoryProfit after all expenses and taxes-$46.0M+24.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$20.9M-8.8% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$110.4M+22.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$87.7M-3.6% YoYR&D Expense HistoryResearch and development spending$56.6M-44.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$13.5M-11.7% YoYIncome Tax HistoryTotal income tax expense$312.0K-40.1% YoYEPS (Basic) HistoryBasic earnings per share-$2.69+68.2% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$2.69+68.2% YoY